NCT00306527 Comparison of Safety, Tolerability and Immunogenicity of Influenza Vaccines in Adults and Elderly Status COMPLETED Phase PHASE3
NCT00304434 Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies. Status COMPLETED Phase PHASE4
NCT00298233 High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza Status COMPLETED Phase PHASE2
NCT00296829 Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly Status COMPLETED Phase PHASE2
NCT00294788 Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines Status UNKNOWN Phase PHASE1/PHASE2
NCT00294099 H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults Status COMPLETED Phase PHASE1/PHASE2
NCT00289510 Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Whole Virion, Vero Cell Derived) Status COMPLETED Phase PHASE1/PHASE2
NCT00283283 Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine Status COMPLETED Phase PHASE2
NCT00263900 TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit Status COMPLETED Phase NA
NCT00258830 Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine Status COMPLETED Phase PHASE4
NCT00258817 Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine Status COMPLETED Phase PHASE4
NCT00253734 Immunogenicity and Safety of Different Doses of Fluzone® Influenza Status COMPLETED Phase PHASE2
NCT00240903 Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine Status COMPLETED Phase PHASE1
NCT00240877 Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024) Status COMPLETED Phase PHASE3
NCT00232947 Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over Status COMPLETED Phase PHASE3